Viking Therapeutics (VKTX) stock, explained like you're 5

Is Viking Therapeutics a small, medium or large cap company?

No. Viking Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.6 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Viking Therapeutics makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves VKTX stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• VKTX Stock Steady After Hours On Positive Obesity Drug Pipeline Progress (Stocktwits)
• Viking Therapeutics Just Raised $575 Million. Here's What It Means for the Obesity Stock's Next Chapter. (The Motley Fool)
• Viking Therapeutics (VKTX) Stock Dropped, So What Is Driving Attention Now? (Yahoo Finance)
• Viking Therapeutics Stock In Focus As Earnings Near And Obesity Trial Advances (Simply Wall Street)
• Viking Therapeutics Prices Upsized $500 Million Offering of Common Stock and Convertible Senior Notes (PR Newswire)

Key terms to know before you follow VKTX

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility